SR Jaiswal, S Zaman, A Chakrabarti, S Sen… - Biology of Blood and …, 2016 - Elsevier
We carried out post-transplantation cyclophosphamide (PTCy)-based haploidentical peripheral blood stem cell transplantation in 51 patients with refractory/relapsed acute …
Despite advances in transplantation techniques and immunosuppressive therapies, graft- versus-host disease (GVHD) remains a significant cause of morbidity and mortality …
KT Hong, HJ Kang, JY Choi, CR Hong… - Biology of Blood and …, 2018 - Elsevier
Haploidentical hematopoietic stem cell transplantation (haplo-HSCT) with post- transplantation cyclophosphamide (PTCy) was performed previously in adults using a …
A Sharma, N Rastogi, G Chatterjee… - Journal of Pediatric …, 2021 - journals.lww.com
Background: Haploidentical family donor is universally available and is fast emerging as an alternative donor choice for children with leukemia needing hematopoietic stem cell …
M Hu, J Li, T Hu, Z Zhang, S Feng, L Xuan… - Leukemia & …, 2024 - Taylor & Francis
This retrospective analysis evaluated the use of anti-thymocyte globulin (ATG) with or without post-transplantation cyclophosphamide (PTCy) for graft-versus-host disease (GvHD) …
D Medina, L Gonzales, D Davalos, M Rosales… - Revista Colombiana de …, 2018 - Elsevier
Objetivo Describir la experiencia en términos de supervivencia y complicaciones de los pacientes llevados a trasplante de células madre hematopoyéticos (TCMH) en los últimos …
In the last few years, haploidentical family donor (HFD) has emerged as a front-runner for alternate donor hematopoietic cell transplantation (HCT) in hematological malignancies …
REVIEW OF LITERATURE: Haploidentical SCT is defined as transplantation of stem cells that involves partially mismatched HLA antigens between recipient and donor, and atleast 1 …